增强微泡超声造影剂对高强度聚焦超声消融效果的研究:实验与临床研究
该研究包含两项随机对照试验,分别以63只兔和143例子宫单发肌瘤患者为对象,探讨SonoVue增强高强度聚焦超声(HIFU)消融效果与SonoVue浓度及HIFU开始时间的关系。实验研究中,给药后60秒开始HIFU时肝脏温度和坏死体积最大;临床研究中,给药后1分钟开始HIFU组的显著灰阶变化率更高、达到大量灰阶变化所需辐照时间更短、消融1 cm³肌瘤所需辐照时间更短、治疗1 mm³肌瘤所用声能更少。结论认为SonoVue可安全用于增强HIFU消融效果,开始HIFU的最佳时间似为给药后1分钟。
要点
- 实验研究中,给药后60秒开始HIFU时肝脏温度和坏死体积最大。
- 临床研究中,1分钟SonoVue组显著灰阶变化率显著高于其他三组。
- 1分钟SonoVue组达到大量灰阶变化及消融1 cm³肌瘤的辐照时间均显著短于其他三组。
核心结论
- SonoVue可安全用于增强HIFU治疗的消融效果,开始HIFU辐照的最佳时间似为给药后1分钟。
研究设计与样本
- 两项随机对照试验,在中國一所大学动物中心及一所大学医院妇科进行。
- 实验研究纳入63只兔,其中3只设为对照组,其余60只均分至三个研究组,分别于HIFU前给予0.03、0.05或0.07 ml/kg的SonoVue。
- 临床研究纳入143例子宫单发肌瘤患者,分为四组:30例仅接受HIFU治疗,其余患者给予相同剂量SonoVue后分别在给药后1、3、5分钟接受HIFU治疗,对应例数分别为32、38和43例。
主要发现
- 实验研究中,给药后60秒开始HIFU辐照时,肝脏最高温度和最大坏死体积被观察到。
- 临床研究中,1分钟SonoVue组的显著灰阶变化率显著高于其他三组。
- 1分钟SonoVue组达到大量灰阶变化所需辐照时间显著短于其他三组。
- 1分钟SonoVue组消融1 cm³肌瘤体积所需辐照时间显著短于其他三组。
- 1分钟SonoVue组治疗1 mm³子宫肌瘤所用声能显著少于其他三组。
临床怎么用
- 本研究中未发生重大并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the relationship between SonoVue ablation enhancement effects on high-intensity focused ultrasound (HIFU) and the concentration of SonoVue and timing of HIFU. DESIGN: Two randomised controlled trials. SETTING: An animal centre in a university and a gynaecological department in a university hospital in China. POPULATION OR SAMPLE: 63 rabbits and 143 patients with a solitary uterine fibroid. METHODS: Among the 63 rabbits, three were assigned to the control group. The other 60 were evenly assigned to three study groups pretreated with 0.03, 0.05 or 0.07 ml/kg of SonoVue before HIFU treatment. Two points in each liver were selected to be treated with HIFU and sonication started at 10, 30, 60, 90, 120, 150, 180, 210, 250 or 300 seconds after the administration of SonoVue, respectively. The 143 patients with solitary uterine fibroids were assigned to four groups: 30 patients were treated using only HIFU; the other patients were pretreated with same dosage of SonoVue and 32, 38 and 43 were treated with HIFU at 1-, 3-, and 5-minutes after administration of SonoVue, respectively. MAIN OUTCOME MEASURES: The relation between SonoVue ablation enhancement effects on HIFU and the concentration of SonoVue and timing of HIFU. RESULTS: In the experimental study, the highest temperature and the largest necrotic volume in the liver were observed when HIFU sonication started at 60 seconds after administration of SonoVue. In the clinical study, the rate of significant grey-scale changes in the 1-minute SonoVue group was significantly greater than in the other three groups. The sonication time to reach massive grey-scale changes measured in the 1-minute SonoVue group was significantly shorter than in in the other three groups. The sonication time for ablating 1 cm3 of fibroid volume in the 1-minute SonoVue group was significantly shorter than in the other three groups. The acoustic energy used in treating 1 mm3 of uterine fibroid in the 1-minute SonoVue group was significantly less than that used in the other three groups. No major complications occurred in this study. CONCLUSIONS: SonoVue could safely be used to enhance the ablation effects of HIFU treatment, and the optimal time to begin HIFU sonication seems to be 1 minute after the administration of SonoVue. TWEETABLE ABSTRACT: SonoVue, a microbubble contrast agent, enhanced the ablation effects of HIFU treatment; the optimal time to begin HIFU sonication appears to be 1 minute after the administration of SonoVue.
引用
- Cheng C, Xiao Z, Huang G, et al. Enhancing ablation effects of a microbubble contrast agent on high-intensity focused ultrasound: an experimental and clinical study. BJOG. 2017. PMID: 28856858. doi:10.1111/1471-0528.14744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。